Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Mark Young Lee , Srinath Chilakamarri Yeshwant , Sreedivya Chava , et al Added: 3 years ago
Aortic stenosis (AS) is the most common valvular heart disease in industrialised countries with a prevalence of about 5 % in the general population aged greater than 75 years. During the past decade, transcatheter aortic valve replacement (TAVR) has emerged as a valuable, minimally invasive treatment option for patients presenting with symptomatic severe AS, who due to their advanced age and… View more
Author(s): Robert Sheldon Added: 5 years ago
ProfessorRobert S. Sheldon discusses arandomized pragmatic trial of strategies of permanent pacemaker versus implantable cardiac monitor in older patients with syncope and bifascicular block. Filmed by Radcliffe Cardiology on-site at HRS 2018 in Boston, US. View more
Author(s): Oholi Tovia-Brodie , Yoav Michowitz , Bernard Belhassen Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) has become the standard therapy in patients with symptomatic severe aortic stenosis and an intermediate or high surgical risk.1,2 Recent promising reports suggest that it will also become standard therapy in low-risk patients.3,4 New conduction disturbances following the procedure requiring permanent pacemaker implantation (PPI) have been well… View more
Job title: Head of the department of Internal Medicine and Cardiology
Prof Christoph Hammerstingl is Head of the Department of Internal Medicine and Cardiology at the Eduardus Hospital in Cologne, DE. He started his career at the University Hospital in Bonn, where he established interventional echocardiography since 2010 for the treatment of mitral and tricuspid valve disease. As an interventionalist he proctored structural cases all over Europe and North America… View more
Research Area(s) / Expertise:

Coronary Interventions

Job title: Consultant cardiologist
Background Dr Ghada Mikhail is a consultant interventional cardiologist at Imperial College Healthcare NHS Trust. She qualified from the Royal Free Hospital School of Medicine, and was awarded an MD from the University of London. She trained at the Royal Brompton and Harefield NHS Trust. She has gained international experience by spending a year in Italy, in a world renowned centre, on an… View more
Author(s): Ana Paula Tagliari , Adriano Nunes Kochi , Bernardo Mastella , et al Added: 3 years ago
Cardiac implantable electronic devices (CIEDs), including permanent pacemakers (PPMs), ICD and CRT devices, are the mainstream therapy for many potentially lethal heart conditions, such as advanced atrioventricular block or sustained ventricular tachycardia or fibrillation. CIEDs can be implanted through endovascular or epicardial routes, with the former used the most because it is less invasive… View more
Author(s): Rikke Esberg Kirkfeldt , Jens Brock Johansen , Jens Cosedis Nielsen Added: 3 years ago
Cardiac implantable electronic device (CIED) therapy is effective and safe. However, infections related to CIED treatment may have devastating consequences, causing significant morbidity, mortality and generating considerable healthcare costs.1–6 Temporal trends in CIED treatment indicate a disproportional increase in CIED infections relative to implantation rates.1,7,8 Reasons for this trend are… View more
Author(s): Charles Kennergren Added: 3 years ago
The implantation of cardiovascular implantable electronic devices (CIEDs) including permanent pacemakers (PPMs), implantable cardioverter-defibrillators (ICDs) and cardiac resynchronisation therapy (CRT-D [with defibrillator] and CRT-P [with pacemaker]) devices are lifesaving procedures, and the expanding indications for device use have led to a marked increase in implantation procedures in… View more
Author(s): Khaldoun G Tarakji , Christopher R Ellis , Pascal Defaye , et al Added: 3 years ago
Over the last few decades an increasing body of evidence has supported the role of cardiovascular implantable electronic devices (CIEDs) including permanent pacemakers (PPMs), implantable cardioverter-defibrillators (ICDs) and cardiac resynchronisation therapy (CRT-D [with defibrillator] and CRT-P [without defibrillator]) in improving quality of life and survival.1 In addition, there has been a… View more
Author(s): Dhanunjaya Lakkireddy Added: 2 years ago
In this interview, Dr Dhanunjaya Lakkireddy (Kansas City Heart Rhythm Institute, Overland Park, KS, US) discusses the outcomes of the multicenter Susruta-IST Registry, which aimed to report upon the outcomes of sinus node sparing surgical thoracoscopic hybrid ablation (SUSRUTA) for inappropriate sinus tachycardia (IST). Questions: 1. Please summarise the aim, study design and endpoints? 2. What… View more